TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-2,780 Cr | ₹77 Cr | ₹-1,781 Cr | ₹-1,651 Cr | ₹-1,549 Cr |
What is the latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-2,780 Cr |
Mar2023 | ₹77 Cr |
Mar2022 | ₹-1,781 Cr |
Mar2021 | ₹-1,651 Cr |
Mar2020 | ₹-1,549 Cr |
How is Cash Flow from Financing Activities of TORRENT PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-2,780 Cr | Negative | |
Mar2023 | ₹77 Cr | Positive | |
Mar2022 | ₹-1,781 Cr | Negative | |
Mar2021 | ₹-1,651 Cr | Negative | |
Mar2020 | ₹-1,549 Cr | - |
Compare Cash Flow from Financing Activities of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹108,462.3 Cr | -3.3% | -5.7% | 28.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 4.1% | -7% | 52% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -3.3% |
-5.7% |
28.7% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses